A study published in the New England Journal of Medicine shows the medication Paxlovid shows “no measurable benefit” for the treatment of COVID-19 in patients 40 to 65-years of age.
principia-scientific.com
0
Share on Telegram
Share on Facebook
Share on Twitter
Share on Reddit